Canine atopic dermatitis Market : Industry Insights, Major Key Players and Current Trends Analysis

SDKI Inc. published a new report on "Global Canine Atopic Dermatitis Market-Forecast 2022-2030". This study includes the statistical and analytical approaches needed to grow the canine atopic dermatitis market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-111665

The canine atopic dermatitis market is estimated to grow from a market value of approximately US $ 138.4 billion in 2022 to approximately US $ 185.9 billion by 2030, with a CAGR of 4.30% during the 2022-2030 forecast period. It is expected.

Canine atopic dermatitis is a skin-related disease that causes allergic symptoms when exposed to allergens. It's a problem. Allergens are usually pollen, dust and mite types. Your pet is unlikely to be protected from these allergens because it is exposed to house dust mite and pollen while it is outdoors. Excessive scratches, itching, hair loss, foul odors, rubbing against carpet, and scaly skin are common symptoms of this problem. Expanding pet ownership around the world is a major driver of growth in the canine atopic dermatitis market during the forecast period. In addition, increased research and development activities for canine atopic dermatitis are driving the growth of the canine atopic dermatitis market worldwide.

According to the 2019-2020 National Pet Owners Survey conducted by the American Pet Product Association (APPA), more than 67% or about 85 million US households own pets, up from 56% in 1988. .. This includes a total of 5.7 million birds, 42.7 million cats, 63.4 million dogs and about 11.5 million freshwater fish. In addition, according to the 2019 People's Dispensary for Diseases (PDSA) Animal Health (PAW) survey, more than 50% of adults in the UK have pets. Of these, more than 24% of adults in the UK own cats, 26% of adults own dogs, and more than 2% of adults own rabbits. Ownership of cats in the UK increased from 10.3 million in 2017 to 10.9 million in 2019, as well as ownership of dogs increased from 9.3 million in 2017 to 9.9 million in 2019.

Sample URL of the report
https://www.sdki.jp/sample-request-111665

However, the use of off-label use may impede the growth of the canine atopic dermatitis market during the forecast period.

Canine atopic dermatitis market segment

canine atopic dermatitis market is by product (sugar corticoid, antihistamine, immunosuppressant, MAb, etc.), by administration method (topical, oral, injectable), and by distribution channel (local, oral, injectable). Veterinary hospitals, retail, e-commerce), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview

canine atopic dermatitis market The canine atopic dermatitis market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

The European region is a major region of the global dog atopic dermatitis market. This is due to the increasing ownership of pets in the region. Meanwhile, the Asia Pacific region is expected to grow at the largest CAGR in the canine atopic dermatitis market during the forecast period. This is due to the growing awareness of people about canine atopic dermatitis and the progress of research and development in the region.

A major key player in the canine atopic dermatitis market

Key players in the canine atopic dermatitis market include Zoetis, Elanco, Virbac, Toray Industries, AB Science, Boehringer Ingelheim and Kindred Biosciences. The study includes a detailed competitive analysis of these major companies in the canine atopic dermatitis market, corporate profiles, recent developments, and key market strategies.

Details of the survey report
https://www.sdki.jp/press-details/global-canine-atopic-dermatitis-market/184

15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.